Andrews AM - Search Results

1

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP. Bengel D, et al. Among authors: andrews am. Mol Pharmacol. 1998 Apr;53(4):649-55. doi: 10.1124/mol.53.4.649. Mol Pharmacol. 1998. PMID: 9547354

2

Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter.

Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch KP, Murphy DL. Kim DK, et al. Among authors: andrews am. Neuropharmacology. 2005 Nov;49(6):798-810. doi: 10.1016/j.neuropharm.2005.08.010. Epub 2005 Sep 23. Neuropharmacology. 2005. PMID: 16183083

3

A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL. Fox MA, et al. Among authors: andrews am. Psychopharmacology (Berl). 2007 Dec;195(2):147-66. doi: 10.1007/s00213-007-0910-0. Epub 2007 Aug 22. Psychopharmacology (Berl). 2007. PMID: 17712549 Review.

4

Gene structure and 5'-flanking regulatory region of the murine serotonin transporter.

Bengel D, Heils A, Petri S, Seemann M, Glatz K, Andrews A, Murphy DL, Lesch KP. Bengel D, et al. Brain Res Mol Brain Res. 1997 Mar;44(2):286-92. doi: 10.1016/s0169-328x(96)00234-3. Brain Res Mol Brain Res. 1997. PMID: 9073170

5

Genetic perspectives on the serotonin transporter.

Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch KP, Uhl G. Murphy DL, et al. Brain Res Bull. 2001 Nov 15;56(5):487-94. doi: 10.1016/s0361-9230(01)00622-0. Brain Res Bull. 2001. PMID: 11750794 Review.

6

Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.

Andrews AM, Murphy DL. Andrews AM, et al. Eur J Pharmacol. 1993 Dec 7;250(2):215-21. doi: 10.1016/0014-2999(93)90384-t. Eur J Pharmacol. 1993. PMID: 8112382

7

2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.

Andrews AM, Murphy DL. Andrews AM, et al. J Pharmacol Exp Ther. 1993 Dec;267(3):1432-9. J Pharmacol Exp Ther. 1993. PMID: 8263805

8

Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.

Andrews AM, Ladenheim B, Epstein CJ, Cadet JL, Murphy DL. Andrews AM, et al. Mol Pharmacol. 1996 Dec;50(6):1511-9. Mol Pharmacol. 1996. PMID: 8967972

9

Cellular localization and expression of the serotonin transporter in mouse brain.

Bengel D, Jöhren O, Andrews AM, Heils A, Mössner R, Sanvitto GL, Saavedra JM, Lesch KP, Murphy DL. Bengel D, et al. Among authors: andrews am. Brain Res. 1997 Dec 19;778(2):338-45. doi: 10.1016/s0006-8993(97)01080-9. Brain Res. 1997. PMID: 9459551

10

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR. Murphy DL, et al. Among authors: andrews am. Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Neuropharmacology. 2008. PMID: 18824000 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters